Amiens, France

Alexandra Dassonville-Klimpt


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Alexandra Dassonville-Klimpt: Innovator in Malaria Treatment**

Introduction

Alexandra Dassonville-Klimpt, an accomplished inventor based in Amiens, France, has made significant contributions to medical science through her innovative research. With one patent to her name, she is dedicated to the advancement of pharmaceutical solutions aimed at combating serious health challenges.

Latest Patents

Her notable patent is centered around "Aminopyridinemethanol compounds and their use." This innovative invention focuses on novel compounds of Formula (I), which includes pharmaceutically acceptable salts or solvates. The primary application of these compounds is in the treatment and prevention of malaria, showcasing her commitment to addressing global health issues through scientific innovation.

Career Highlights

Throughout her career, Alexandra has been associated with esteemed institutions such as Université Amiens Picardie Jules Verne and Centre Hospitalier Universitaire d'Amiens. Her roles at these organizations highlight her passion for research and her dedication to improving healthcare.

Collaborations

Alexandra has collaborated with skilled professionals like Pascal Sonnet and Guillaume Bentzinger. These partnerships reflect her collaborative spirit and her ability to work effectively within multidisciplinary teams, enhancing her research and innovation efforts.

Conclusion

In summary, Alexandra Dassonville-Klimpt is a remarkable inventor with a commitment to developing solutions that can significantly impact the fight against malaria. Her patent on aminopyridinemethanol compounds represents a vital step forward in medical treatment. Her work at reputable institutions further establishes her as a key player in the field of pharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…